Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc
Code | Size | Price |
---|
TAR-T41023-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T41023-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc is a cleavable linker compound employed for the synthesis of antibody-drug conjugates (ADCs).
CAS:
894096-02-7
Molecular Weight:
748.738
Purity:
0.98
SMILES:
COC(=O)[C@H]1O[C@@H](Oc2ccc(CO)cc2NC(=O)CCNC(=O)OCC2c3ccccc3-c3ccccc23)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
References
Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.